A Danish nationwide study of individuals suspected of FH referred from general practice to lipid clinics: Clinical characteristics, plasma lipoprotein(a) and final diagnosis

Autor: Hedegaard, B.S., Bork, C.S., Klausen, I.C., Nordestgaard, B.G., Schmidt, E.B., Joensen, A.M.

Publikováno v: In Atherosclerosis August 2022 355

Treatment of Hypercholesterolaemia with PCSK9 Inhibitors in Denmark. Assessment of real-life data; Extent and Efficacy after the first years of clinical use

Autor: Mulverstedt, S, Klausen, I.C., Kanstrup, H, Knold, Jakob, L, J. Andersen, Theilade, Juliane, Yafasov, Karim Maksutovich, Jensen, J. S., Martinsen, M H, Korsgaard Thomsen, Kristian, Henriksen, Finn Lund, Schmidt, Erik Berg, Clausen, J., Egstrup, Kenneth, Heitmann, Merete

Publikováno v: Mulverstedt, S, Klausen, I C, Kanstrup, H, Knold, J, L, J A, Theilade, J, Yafasov, K M, Jensen, J S, Martinsen, M H, Korsgaard Thomsen, K, Henriksen, F L, Schmidt, E B, Clausen, J, Egstrup, K & Heitmann, M 2019, ' Treatment of Hypercholesterolaemia with PCSK9 Inhibitors in Denmark. Assessment of real-life data; Extent and Efficacy after the first years of clinical use ', European Heart Journal, vol. 40, no. Suppl. 1, 2981 . https://doi.org/10.1093/eurheartj/ehz745.0002

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::4ee37d54db7fa4dadd83899526b44470
https://portal.findresearcher.sdu.dk/da/publications/e6130c06-8e8f-4fba-af2b-a987da811db0

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment of hypercholesterolaemia with pcsk-9-inhibitors in denmark. Assessment of real-life data; extent and efficacy after the first years of clinical use

Autor: Mülverstedt, S., Klausen, I.C., Martinsen, M.H., Kanstrup, H., Thomsen, K.K., Bech, J., Henriksen, F.L., Knold, J., Andersen, L.J., Kobbelgaard, L.H., Theilade, J., Clausen, J., Yafasov, K.M., Egstrup, K., Jensen, J.S., Heitmann, M.

Publikováno v: In Atherosclerosis August 2019 287:e39-e40

The apolipoprotein ε4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction:A substudy of the Scandinavian Simvastatin Survival Study(4S)

Autor: Gerdes, Lars Ulrik, Gerdes, Christian, Kervinen, K., Savolainen, M., Klausen, I.C., Hansen, P.S., Kesäniemi, Y.A., Færgeman, Ole

Publikováno v: Gerdes, L U, Gerdes, C, Kervinen, K, Savolainen, M, Klausen, I C, Hansen, P S, Kesäniemi, Y A & Færgeman, O 2000, ' The apolipoprotein ε4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : A substudy of the Scandinavian Simvastatin Survival Study(4S) ', Circulation, no. 101, pp. 1366-1371 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::c67f1d5eb86c01487086c4e79e3677c8
https://pure.au.dk/portal/da/publications/the-apolipoprotein-4-allele-determines-prognosis-and-the-effect-on-prognosis-of-simvastatin-in-survivors-of-myocardial-infarction(3d28c8d0-befc-11da-bee9-02004c4f4f50).html